Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
- Al-Samkari H, Leaf RSK, Dzik WH, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. 2020;136(4):489-500.
- Tang N, Bai H, Chen X, et al. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020 Mar 27. doi: 10.1111/jth.14817. Online ahead of print.
- Pesavento R, Ceccato D, Pasquetto G, et al. The hazard of (sub)therapeutic doses of anticoagulants in non-critically ill patients with Covid-19: the Padua province experience. J Thromb Haemost. 2020 Jul 21. doi: 10.1111/jth.15022. Online ahead of print.
- Patell R, Bogue T, Koshy A, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood 2020;136(11):1342-1346.
- Roberts LN, Whyte MB, Georgiou L, et al. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood (2020) 136(11):1347-1350.
- Lemos ACB, do Espirito Santo DA, Salvetti MC, et al. Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID). Thromb Res. 2020;196:359-366.
- Rosovsky, RP, Sanfilippo, KM, Wang, TF, et al. Anticoagulation practice patterns in COVID-19: A global survey. Res Pract Thromb Haemost. 2020;4:969-983.
Disclosure statements are available on the authors' profiles: